相似文献
1
The global state of psoriasis disease epidemiology: a workshop report.
Br J Dermatol. 2017 Jul;177(1):e4-e7. doi: 10.1111/bjd.15610. Epub 2017 May 28.
2
The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012.
Br J Dermatol. 2013 Aug;169(2):283-6. doi: 10.1111/bjd.12347.
3
Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol. 2013 Aug;40(8):1407-9. doi: 10.3899/jrheum.130450.
4
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol. 2014 Jun;41(6):1194-6. doi: 10.3899/jrheum.140168.
5
GRAPPA Trainees Symposium 2015: A Report from the GRAPPA 2015 Annual Meeting.
J Rheumatol. 2016 May;43(5):952-8. doi: 10.3899/jrheum.160113.
6
GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
J Rheumatol. 2014 Jun;41(6):1200-5. doi: 10.3899/jrheum.140170.
7
Getting under the Skin: Report from the International Psoriasis Council Workshop on the Role of Stress in Psoriasis.
Front Psychol. 2016 Feb 2;7:87. doi: 10.3389/fpsyg.2016.00087. eCollection 2016.
8
Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting.
J Rheumatol. 2011 Mar;38(3):530-9. doi: 10.3899/jrheum.101115.
9
Proceedings of the International Workshop on Current Challenges in Liquid and Glass Science, (The Cosener's House, Abingdon 10-12 January 2007).
J Phys Condens Matter. 2007 Oct 17;19(41):410301. doi: 10.1088/0953-8984/19/41/410301.
10
Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol. 2012 Nov;39(11):2181-3. doi: 10.3899/jrheum.120818.
引用本文的文献
1
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies.
Clin Rev Allergy Immunol. 2025 Aug 7;68(1):79. doi: 10.1007/s12016-025-09089-4.
2
From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP.
Inflammation. 2025 Jul 18. doi: 10.1007/s10753-025-02303-7.
3
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.
Int J Dermatol. 2025 Sep;64(9):1599-1606. doi: 10.1111/ijd.17848. Epub 2025 May 19.
4
Global, regional and national disparities and temporal trends of common autoimmune disease burdens among children and adolescents from 1990 to 2019.
BMJ Glob Health. 2025 Apr 3;10(4):e017187. doi: 10.1136/bmjgh-2024-017187.
5
Analysis of the Reduction in the Duration of Sick Leave for 32,512 Psoriasis Patients Following the Integration of Targeted Therapies for Psoriatic Disease into the Brazilian Healthcare System: a Retrospective Cohort Study.
Psoriasis (Auckl). 2025 Mar 28;15:105-116. doi: 10.2147/PTT.S513878. eCollection 2025.
6
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models.
Mol Diagn Ther. 2025 May;29(3):345-366. doi: 10.1007/s40291-025-00776-8. Epub 2025 Apr 1.
7
Safety, Pharmacokinetics, and Efficiency of JS005, a Novel Anti-interleukin-17A Monoclonal Antibody, in Healthy Chinese Adults and Patients with Moderate to Severe Psoriasis.
Acta Derm Venereol. 2025 Mar 26;105:adv41105. doi: 10.2340/actadv.v105.41105.
8
Novel genetic insight for psoriasis: integrative genome-wide analyses in 863 080 individuals and proteome-wide Mendelian randomization.
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf032.
9
Enhanced skin penetration of curcumin by a nanoemulsion-embedded oligopeptide hydrogel for psoriasis topical therapy.
RSC Med Chem. 2025 Jan 2. doi: 10.1039/d4md00781f.
10
infection and its impact on psoriasis: a systematic review and meta-analysis.
Front Med (Lausanne). 2024 Dec 6;11:1500670. doi: 10.3389/fmed.2024.1500670. eCollection 2024.
本文引用的文献
1
Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study.
Br J Dermatol. 2017 Mar;176(3):650-658. doi: 10.1111/bjd.15021. Epub 2016 Dec 22.
2
Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A population-based cross-sectional study.
J Allergy Clin Immunol. 2016 Aug;138(2):509-16. doi: 10.1016/j.jaci.2016.03.031. Epub 2016 Apr 28.
3
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
J Invest Dermatol. 2015 Nov;135(11):2632-2640. doi: 10.1038/jid.2015.208. Epub 2015 Jun 8.
4
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.
J Clin Cell Immunol. 2014 Apr;5(2). doi: 10.4172/2155-9899.1000202.
5
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.
Br J Dermatol. 2015 Jun;172(6):1613-1620. doi: 10.1111/bjd.13539. Epub 2015 Mar 17.
6
Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews.
JAMA Dermatol. 2014 Sep;150(9):945-51. doi: 10.1001/jamadermatol.2014.709.
7
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
J Am Acad Dermatol. 2014 May;70(5):871-81.e1-30. doi: 10.1016/j.jaad.2013.12.018. Epub 2014 Feb 24.
8
New insights into the epidemiology of childhood atopic dermatitis.
Allergy. 2014 Jan;69(1):3-16. doi: 10.1111/all.12270. Epub 2013 Nov 21.
9
The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.
J Invest Dermatol. 2014 Jun;134(6):1527-1534. doi: 10.1038/jid.2013.446. Epub 2013 Oct 28.
10
Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries.
Br J Dermatol. 2013 Sep;169(3):710-4. doi: 10.1111/bjd.12344.
Zotero 插件